About 2 results found for searched term "Oritavancin" (0.213 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M4885 | Oritavancin | Anti-infection |
| LY333328 | ||
| Oritavancin is a Lipoglycopeptide Antibacterial. The mechanism of action of oritavancin is as a Cytochrome P450 2C19 Inhibitor, Cytochrome P450 2C9 Inhibitor, Cytochrome P450 3A4 Inducer, and Cytochrome P450 2D6 Inducer. The chemical classification of oritavancin is Lipoglycopeptides. | ||
| M6133 | Oritavancin diphosphate | Antibiotic |
| LY 333328 diphosphate | ||
| Oritavancin is approved for the treatment of adult patients with acute bacterial skin and skin structure infections (SSSIs) caused by or suspected to be caused by susceptible isolates of designated gram-positive microorganisms. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
